Table 6Baseline absolute risks of CVD events for patients with stable CAD taken from IDEAL (Pedersen, T. R., Faergeman, O., Kastelein, J. J. et al, 2005) & TNT (LaRosa, J. C., Grundy, S. M., Waters, D. D. et al, 2005)

meanalphabeta
MI0.06659613459110
Stroke0.03479646298826
Transient ischemic attack0.04994013299126
Peripheral artery disease0.04748812509205
Heart failure0.03035434499006
Revascularisation0.16700382879168
Unstable angina0.05282097438712
Cardiovascular death0.03648862359220

From: Appendix C, Health Economic Modelling

Cover of Lipid Modification
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet].
NICE Clinical Guidelines, No. 67.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce anypart of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.